title: Zanamivir treatment is equally effective for both influenza A and influenza B.
authors.forename: Naoki
authors.initials: N
authors.lastname: Kawai
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Ikematsu
authors.forename: Norio
authors.initials: N
authors.lastname: Iwaki
authors.forename: Osame
authors.initials: O
authors.lastname: Tanaka
authors.forename: Yasuhito
authors.initials: Y
authors.lastname: Yamanishi
authors.forename: Nobuo
authors.initials: N
authors.lastname: Hirotsu
authors.forename: Seizaburo
authors.initials: S
authors.lastname: Kashiwagi
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009980:Influenza A virus / Q000187:drug effects*; D009981:Influenza B virus / Q000187:drug effects*; D007251:Influenza, Human / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D053243:Zanamivir / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D053243:Zanamivir